Published in J Neurochem on March 20, 2010
Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent molecular dynamics study. PLoS One (2012) 1.01
Antioxidant gene therapy against neuronal cell death. Pharmacol Ther (2013) 0.92
Methionine-35 of aβ(1-42): importance for oxidative stress in Alzheimer disease. J Amino Acids (2011) 0.85
Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo. Biochemistry (2011) 0.85
Design of β-amyloid aggregation inhibitors from a predicted structural motif. J Med Chem (2012) 0.82
Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer. ACS Chem Neurosci (2011) 0.77
miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675. Am J Transl Res (2016) 0.77
Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF. Am J Transl Res (2016) 0.76
Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease. J Amino Acids (2011) 0.76
The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo. Antioxid Redox Signal (2015) 0.75
Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42. Int J Alzheimers Dis (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Alzheimer's disease. N Engl J Med (2004) 7.50
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 7.26
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem (2002) 5.63
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
Oxidative stress and neurodegeneration: where are we now? J Neurochem (2006) 5.44
On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75
A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods (1988) 4.70
Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A (2009) 3.86
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem (2009) 3.66
Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol (2001) 3.26
Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A (2009) 3.06
Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem (2008) 2.90
Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc (2004) 2.79
Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem (2001) 2.77
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci (1996) 2.69
In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42) Neurobiol Aging (2000) 2.67
Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem (2003) 2.31
Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A (1999) 2.19
In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci U S A (2004) 2.13
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis (2009) 2.12
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med (2007) 2.08
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res (2002) 1.97
Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol (2008) 1.93
Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging (1998) 1.91
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol (2000) 1.69
Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. J Mol Biol (2008) 1.62
A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization. J Am Chem Soc (2003) 1.55
Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem (1993) 1.52
Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol (1989) 1.50
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem (2001) 1.49
Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J Biol Chem (2002) 1.39
Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis (2005) 1.39
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. Int J Biochem Cell Biol (2007) 1.36
Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem (2008) 1.36
C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity. Proc Natl Acad Sci U S A (2008) 1.32
Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35). J Am Chem Soc (2001) 1.32
Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22
In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med (2009) 1.20
Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. Methods Enzymol (2006) 1.18
Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. J Biol Chem (2003) 1.14
The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta (2004) 1.09
Confocal microscopic imaging of [Ca2+]i in cultured rat hippocampal neurons following exposure to N-methyl-D-aspartate. J Physiol (1992) 1.09
Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. J Vis Exp (2009) 1.04
Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution. J Biol Chem (2004) 1.04
Determination of Peptide oligomerization state using rapid photochemical crosslinking. Methods Mol Biol (2005) 0.99
Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42. Peptides (2002) 0.97
Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun (2006) 0.96
Sulfated polysaccharides promote the assembly of amyloid beta(1-42) peptide into stable fibrils of reduced cytotoxicity. J Biol Chem (2008) 0.93
Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry (2005) 0.93
Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers. J Biol Chem (2002) 0.91
Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Res Bull (1999) 0.88
Evaluation of MTT assay for measurement of emodin-induced cytotoxicity. Assay Drug Dev Technol (2006) 0.85
Role of methionine 35 in the intracellular Ca2+ homeostasis dysregulation and Ca2+-dependent apoptosis induced by amyloid beta-peptide in human neuroblastoma IMR32 cells. J Neurochem (2008) 0.80
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res (2002) 3.79
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem (2009) 3.66
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol (2010) 2.71
Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform. J Am Chem Soc (2005) 2.19
High-resolution X-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract. J Mol Biol (2003) 2.02
Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci (2006) 1.99
Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res (2006) 1.80
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest (2003) 1.59
Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus. Proc Natl Acad Sci U S A (2007) 1.55
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol (2010) 1.54
Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin. Biochemistry (2005) 1.50
Structure determination of micelle-like intermediates in amyloid beta -protein fibril assembly by using small angle neutron scattering. Proc Natl Acad Sci U S A (2001) 1.41
Altered phase diagram due to a single point mutation in human gammaD-crystallin. Proc Natl Acad Sci U S A (2007) 1.32
C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity. Proc Natl Acad Sci U S A (2008) 1.32
Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins. J Am Chem Soc (2011) 1.25
Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol (2007) 1.20
The structure of Abeta42 C-terminal fragments probed by a combined experimental and theoretical study. J Mol Biol (2009) 1.19
Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10
Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01. ACS Chem Neurosci (2012) 1.04
Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. J Vis Exp (2009) 1.04
Aβ(39-42) modulates Aβ oligomerization but not fibril formation. Biochemistry (2011) 1.01
A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics (2012) 1.01
Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice. Neurobiol Aging (2006) 1.01
C-terminal turn stability determines assembly differences between Aβ40 and Aβ42. J Mol Biol (2012) 1.00
Polyglutamine repeat length-dependent proteolysis of huntingtin. Neurobiol Dis (2002) 1.00
Determination of Peptide oligomerization state using rapid photochemical crosslinking. Methods Mol Biol (2005) 0.99
Liquid-solid transition in nuclei of protein crystals. Proc Natl Acad Sci U S A (2003) 0.98
Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity. Biochemistry (2010) 0.97
Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments. Biochemistry (2010) 0.96
Effect of polyethylene glycol on the liquid-liquid phase transition in aqueous protein solutions. Proc Natl Acad Sci U S A (2002) 0.94
Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomark (2012) 0.91
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers. Brain (2012) 0.91
Phase behavior of mixtures of human lens proteins Gamma D and Beta B1. Proc Natl Acad Sci U S A (2010) 0.91
A key role for lysine residues in amyloid β-protein folding, assembly, and toxicity. ACS Chem Neurosci (2012) 0.90
A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease. PLoS One (2013) 0.90
Effects of different amyloid β-protein analogues on synaptic function. Neurobiol Aging (2012) 0.90
Pathological crystallization of human immunoglobulins. Proc Natl Acad Sci U S A (2012) 0.90
Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms. ChemMedChem (2012) 0.89
Oligomerization and phase transitions in aqueous solutions of native and truncated human beta B1-crystallin. Biochemistry (2005) 0.88
Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone. Biochem J (2011) 0.87
Quasielastic light scattering for protein assembly studies. Methods Mol Biol (2005) 0.87
Structure of cholesterol helical ribbons and self-assembling biological springs. Proc Natl Acad Sci U S A (2007) 0.86
Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med (2012) 0.86
Molecular basis for preventing α-synuclein aggregation by a molecular tweezer. J Biol Chem (2014) 0.85
Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin. Proc Natl Acad Sci U S A (2011) 0.85
Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo. Biochemistry (2011) 0.85
RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity. PLoS One (2009) 0.85
Phase transitions in human IgG solutions. J Chem Phys (2013) 0.85
Thickness-radius relationship and spring constants of cholesterol helical ribbons. Proc Natl Acad Sci U S A (2009) 0.85
C-terminal tetrapeptides inhibit Aβ42-induced neurotoxicity primarily through specific interaction at the N-terminus of Aβ42. J Med Chem (2011) 0.84
Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? Expert Rev Neurother (2006) 0.84
Zn2+-Aβ40 complexes form metastable quasi-spherical oligomers that are cytotoxic to cultured hippocampal neurons. J Biol Chem (2012) 0.83
Rational design of β-sheet ligands against Aβ42-induced toxicity. J Am Chem Soc (2011) 0.83
En route to early diagnosis of Alzheimer's disease--are we there yet? Trends Biotechnol (2005) 0.82
Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected N(alpha)-(omega-Aminoalkyl)amino Acids and N(alpha)-(omega-Carboxyalkyl)amino Acids. J Org Chem (1997) 0.82
Design of β-amyloid aggregation inhibitors from a predicted structural motif. J Med Chem (2012) 0.82
Observation of liquid-liquid phase separation for eye lens gammaS-crystallin. Proc Natl Acad Sci U S A (2003) 0.82
Molecular tweezers targeting transthyretin amyloidosis. Neurotherapeutics (2014) 0.82
Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations. Dement Geriatr Cogn Disord (2012) 0.82
Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation. Mol Pharm (2014) 0.81
Preparation of stable amyloid β-protein oligomers of defined assembly order. Methods Mol Biol (2012) 0.79
Molecular tweezers inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism. ACS Chem Biol (2015) 0.79
Application of photochemical cross-linking to the study of oligomerization of amyloidogenic proteins. Methods Mol Biol (2012) 0.79
Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease. J Vis Exp (2010) 0.78
Transformation of oligomers of lipidated peptide induced by change in pH. Mol Pharm (2015) 0.77
The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms. J Alzheimers Dis (2013) 0.76
A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors. ChemMedChem (2012) 0.76
Tranilast binds to aβ monomers and promotes aβ fibrillation. Biochemistry (2013) 0.75
Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation. Chem Commun (Camb) (2016) 0.75
Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos. Environ Health Perspect (2016) 0.75
Exact modeling of cylindrical metal-dielectric multilayers beyond the effective medium approximation. Opt Lett (2014) 0.75